Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-003358)

Filing Details

Accession Number:: 0001209191-20-003358
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-14 18:07:09
Reporting Period:: 2020-01-10

Accepted Time:: 2020-01-14 18:07:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1016169	Antares Pharma Inc.	ATRS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
901056	Marvin Samson	C/O Antares Pharma, Inc. 100 Princeton South, Suite 300 Ewing NJ 08628		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-01-10	56	$2.66	51,807	No	4	M	Direct
Common Stock	Disposition	2020-01-10	56	$4.50	51,751	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-01-10	56	$0.00	56	$2.66

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2018-06-07	2027-06-06	No	4	M	Direct

Footnotes

The stock option exercise and sale of common stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established in connection with estate planning and represents the remaining balance of a previously unexercised option grant to be transacted under the plan.
The options vested and became exercisable in four quarterly installments over the one-year period following the grant date of June 7, 2017.